Live Breaking News & Updates on Mirum Pharmaceuticals Trading
Stay updated with breaking news from Mirum pharmaceuticals trading. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) Director Saira Ramasastry sold 5,000 shares of Mirum Pharmaceuticals stock in a transaction on Wednesday, June 5th. The shares were sold at an average price of $25.68, for a total value of $128,400.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, […] ....
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report)’s stock price hit a new 52-week low during trading on Thursday . The company traded as low as $23.14 and last traded at $23.47, with a volume of 36618 shares traded. The stock had previously closed at $24.02. Wall Street Analysts Forecast Growth A number of equities […] ....
Cantor Fitzgerald reaffirmed their overweight rating on shares of Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) in a research report sent to investors on Monday morning, Benzinga reports. The firm currently has a $50.00 target price on the stock. Other research analysts have also recently issued research reports about the stock. JMP Securities reaffirmed a market […] ....
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) CFO Eric Bjerkholt bought 10,000 shares of the firm’s stock in a transaction dated Monday, September 11th. The shares were acquired at an average price of $29.65 per share, for a total transaction of $296,500.00. Following the acquisition, the chief financial officer now directly owns 10,000 shares […] ....
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) SVP Jolanda Howe sold 915 shares of Mirum Pharmaceuticals stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $25.65, for a total transaction of $23,469.75. Following the completion of the transaction, the senior vice president now owns 3,459 shares in […] ....